XDx Poised to Achieve Break-Even in 2010 BRISBANE, Calif.–(HSMN NewsFeed)–XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, today announced the completion of a Ser…
Diagnostics, Venture Capital
XDx, molecular diagnostics, personalized medicine

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “XDx Completes $14.4 Million Series G Financing”
Leave a Comment